MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

03 May 2024 Evaluate
The sales declined to Rs. 939.31 millions for the March 2024 quarter as compared to Rs. 1194.06 millions during the corresponding quarter last year.Profit after Tax for the quarter ended March 2024 saw a decline of -48.95% from Rs. 161.54 millions to Rs. 82.47  millions.Operating profit for the quarter ended March 2024 rose to 187.25 millions as compared to 161.86 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 939.31 1194.06 -21.33 3786.77 4030.44 -6.05 3786.77 4030.44 -6.05
Other Income 45.27 7.83 478.16 75.08 56.78 32.23 75.08 56.78 32.23
PBIDT 187.25 161.86 15.69 743.73 603.56 23.22 743.73 603.56 23.22
Interest 2.18 31.79 -93.14 65.07 83.84 -22.39 65.07 83.84 -22.39
PBDT 185.07 94.20 96.46 678.66 483.85 40.26 678.66 483.85 40.26
Depreciation 62.31 25.30 146.28 256.01 95.54 167.96 256.01 95.54 167.96
PBT 122.76 68.90 78.17 422.65 388.31 8.84 422.65 388.31 8.84
TAX 40.29 -92.64 -143.49 129.17 -16.34 -890.51 129.17 -16.34 -890.51
Deferred Tax 19.02 -48.04 -139.59 55.74 -35.93 -255.13 55.74 -35.93 -255.13
PAT 82.47 161.54 -48.95 293.48 404.65 -27.47 293.48 404.65 -27.47
Equity 233.92 221.65 5.54 233.92 221.65 5.54 233.92 221.65 5.54
PBIDTM(%) 19.93 13.56 47.06 19.64 14.98 31.15 19.64 14.98 31.15
Peers
Company Name CMP
Godrej Industries 1085.75
SRF 2483.95
BASF India 3482.30
Pidilite Inds. 1486.05
Tata Chemicals 628.60
View more..